Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma

被引:4
|
作者
LiLing Luo [1 ,2 ,3 ]
Lei Zhao [1 ,2 ,3 ]
Mian Xi [1 ,2 ,3 ]
LiRu He [1 ,2 ,3 ]
JingXian Shen [1 ,4 ,3 ]
QiaoQiao Li [1 ,2 ,3 ]
ShiLiang Liu [1 ,2 ,3 ]
Peng Zhang [1 ,2 ,3 ]
Dan Xie [1 ,3 ]
MengZhong Liu [1 ,2 ,3 ]
机构
[1] Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[2] Department of Radiation Oncology, Sun Yat-sen University Cancer Center
[3] Collaborative Innovation Center for Cancer Medicine
[4] Medical Imaging and Interventional Center, Sun Yat?sen University Cancer
关键词
D O I
暂无
中图分类号
R735.1 [食管肿瘤];
学科分类号
摘要
Background: Insulin?like growth factor?binding protein?3(IGFBP?3) is suggested to predict the radiosensitivity and/or prognosis of patients with esophageal squamous cell carcinoma(ESCC). The present study was designed to investi?gate the clinical and prognostic efects of IGFBP?3 on ESCC.Methods: IGFBP?3 was detected by immunohistochemistry in parain?embedded tissues from 70 ESCC patients treated with radiotherapy alone and further examined by western blotting analysis in 10 pairs of fresh ESCC tissues and adjacent non?malignant esophageal specimens. Receiver operating characteristic(ROC) analysis was used to determine cut?of scores for tumor positivity and to evaluate patient survival status. The χ2 test was performed to analyze the association of IGFBP?3 expression with clinical characteristics and radiotherapy response. Associations between prognostic outcomes and IGFBP?3 expression were investigated using Kaplan–Meier analysis and the Cox proportional hazards model.Results: The threshold for IGFBP?3 positivity was set to greater than 65% [area under the ROC curve(AUC)(45.7%) were deined as having high IGFBP?3 expression= 0.690, P < 0.019]. Of the 70 ESCC patient tissues tested, 32. The levels of IGFBP?3 protein expression were decreased in 70.0%(7 of 10) of ESCC tissues compared with adjacent non?malignant esophageal tissue. In addition, IGFBP?3 expression was associated with pathologic classiication(P < 0.05 for T, N, and M categories and clinical stage). Patients with elevated protein level of IGFBP?3 in the tumor had an improved radiotherapy response and prolonged overall survival(P < 0.001).Conclusions: High level of IGFBP?3 expression in ESCC associates with early clinical stages and are predictive for favorable survival of the patients treated with radiotherapy.
引用
收藏
页码:514 / 521
页数:8
相关论文
共 50 条
  • [31] Deregulation of insulin-like growth factor binding protein-3 through epidermal growth factor receptor in esophageal carcinoma
    Takaoka, M
    Andl, CD
    Oyama, K
    Harada, H
    Grimberg, A
    Kobayashi, M
    Naomoto, Y
    Nakagawa, H
    GASTROENTEROLOGY, 2004, 126 (04) : A36 - A36
  • [32] Insulin-like growth factor binding protein-3 (IGFBP-3) genetic variant and the risk of esophageal squamous cell carcinoma in a Chinese population
    Yang, H. -P.
    Liu, J. -F.
    Rao, J.
    Zhang, X. -M.
    Qian, H. -L.
    Niu, X. -Q.
    Zhao, Z. -L.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (02): : 4146 - 4153
  • [33] Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa
    Mallipeddi, R
    Wessagowit, V
    South, AP
    Robson, AM
    Orchard, GE
    Eady, RAJ
    McGrath, JA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (05) : 1302 - 1309
  • [34] Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients
    Haugaard, SB
    Andersen, O
    Hansen, BR
    Orskov, H
    Andersen, UB
    Madsbad, S
    Iversen, J
    Flyvbjerg, A
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (12): : 1565 - 1573
  • [35] Clinical significance of type 1 insulin-like growth factor receptor and insulin-like growth factor binding protein-3 expression in squamous cell carcinoma of head and neck
    Jun, H.
    Chang, M.
    Ko, Y.
    Ahn, Y.
    Jeong, H.
    Son, Y.
    Baek, J.
    Park, Y.
    Park, K.
    Ahn, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3
    Campbell, PG
    Durham, SK
    Suwanichkul, A
    Hayes, JD
    Powell, DR
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 275 (02): : E321 - E331
  • [37] Characterization of glycosaminoglycan-binding domains present in insulin-like growth factor-binding protein-3
    Fowlkes, JL
    Serra, DM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (25) : 14676 - 14679
  • [38] INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 PROTEOLYSIS IS INDUCED AFTER ELECTIVE SURGERY
    DAVENPORT, ML
    ISLEY, WL
    PUCILOWSKA, JB
    PEMBERTON, LB
    LYMAN, B
    UNDERWOOD, LE
    CLEMMONS, DR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (02): : 590 - 595
  • [39] CLONING AND CHARACTERIZATION OF THE PROMOTER FOR THE RAT INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 GENE
    ALBISTON, AL
    SAFFERY, R
    HERINGTON, AC
    ENDOCRINOLOGY, 1995, 136 (02) : 696 - 704
  • [40] Insulin-like Growth Factor-binding Protein-3 in Breast Cancer: Analysis with Tissue Microarray
    Sheen-Chen, Shyr-Ming
    Zhang, Hao
    Huang, Chao-Cheng
    Tang, Rei-Ping
    ANTICANCER RESEARCH, 2009, 29 (04) : 1131 - 1135